Elisheva Lew

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Topics

Glycemic Control

Patient Reported

Systemic Sclerosis

Top Venues

Diabetes, obesity & metabolism

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Rosemarie Lajara, Caroline Heller, Kevin M Pantalone, Elisheva Lew, Xuan Li, Terry Dex, C Rachel Kilpatrick
iGlarLixi vs. premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: SoliComplex real-world study. Diabetes, obesity & metabolism (2023)
Rosemarie Lajara, Caroline Heller, Kevin M Pantalone, Elisheva Lew, Xuan Li, Terry Dex, Catherine Rachel Kilpatrick
iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study. Diabetes, obesity & metabolism (2023)
Rosemarie Lajara, Caroline Heller, Kevin M Pantalone, Elisheva Lew, Xuan Li, Terry Dex, C Rachel Kilpatrick
iGlarLixi vs. premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: SoliComplex real-world study. Diabetes, obesity & metabolism (2023)
William H Polonsky, Francesco Giorgino, Julio Rosenstock, Katherine Whitmire, Elisheva Lew, Mathieu Coudert, Agustina Alvarez, Charlie J Nicholls, Rory J McCrimmon
Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial. Diabetes, obesity & metabolism 24 (12) (2022)
Denis Raccah, Bruno Guerci, Mayank Ajmera, Keith Davis, Juliana Meyers, Elisheva Lew, Alka Shaunik, Lawrence Blonde
Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis. Endocrinology, diabetes & metabolism 2 (3) (2019)
Edward B Jude, Caroline O'Leary, Melissa Myland, Mark Nixon, Nick Gooch, Alka Shaunik, Elisheva Lew
Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real-world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN). Endocrinology, diabetes & metabolism 3 (1) (2019)
Liyue Tong, Chunshen Pan, Hongwei Wang, Monica Bertolini, Elisheva Lew, Luigi F Meneghini
Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database. Diabetes, obesity & metabolism 20 (4) (2017)